Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.
about
Renin-angiotensin system blockade: Its contribution and controversyThe ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Pleiotropic Roles in Cancer.Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancerExpression and clinical significance of angiotensin II type 1 receptor in human hepatocellular carcinoma.The use of angiotensin II receptor antagonists to increase the efficacy of radiotherapy in cancer treatment.Angiotensin 1-7 inhibits angiotensin II-stimulated head and neck cancer progression.Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulationmiR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness.Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer.FGF2-mediated reciprocal tumor cell-endothelial cell interplay contributes to the growth of chemoresistant cells: a potential mechanism for superficial bladder cancer recurrence.Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy.Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer
P2860
Q26827221-C4FE86DB-FC36-4636-A131-729B8FA621DFQ33645806-E3F8C10E-BA55-4928-A6AC-EC82D5B2C87BQ35618447-BF68E84F-6FD0-4103-AB57-9A0DA61D259EQ37434424-B155B6FF-7AC2-4779-930E-8A831DA2BE33Q38294600-D3024A6F-6452-4B7D-AADD-DC404544530FQ38707625-5CB82B3F-E6DC-4412-BFFF-15F95092A5BBQ41612891-3BB0F2F3-B4D9-42FB-A8D7-AC627461799EQ47134856-61BCEB72-1A8F-4DF0-BE32-7A39809C91D8Q47863448-335AF765-C197-479C-9F45-18EF081A5864Q48131792-40C92F7B-678C-472F-BD3B-D8C47C8C3B3DQ51675463-30E60A2E-7DA0-4559-86EA-BB73252389C7Q53011547-2E21C47A-B2B2-4331-8EFB-8E7B384E7396Q58798456-E04DF995-BE63-4C45-89A0-AB3D91A97FF0
P2860
Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Acquired platinum resistance e ...... 1 receptor in bladder cancer.
@en
Acquired platinum resistance e ...... 1 receptor in bladder cancer.
@nl
type
label
Acquired platinum resistance e ...... 1 receptor in bladder cancer.
@en
Acquired platinum resistance e ...... 1 receptor in bladder cancer.
@nl
prefLabel
Acquired platinum resistance e ...... 1 receptor in bladder cancer.
@en
Acquired platinum resistance e ...... 1 receptor in bladder cancer.
@nl
P2093
P2860
P356
P1476
Acquired platinum resistance e ...... 1 receptor in bladder cancer.
@en
P2093
A Miyajima
H Shirakawa
S Shirotake
Y Miyazaki
P2860
P2888
P304
P356
10.1038/BJC.2011.399
P407
P50
P577
2011-10-04T00:00:00Z